Clinical Trial Update: Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study. [Phase 1]

View source ↗

Summary

Phase 1 feasibility study assessing neoadjuvant hypofractionated stereotactic body radiotherapy before surgery for hepatocellular carcinoma; recruitment is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University Hospital, Lille | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING